News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,034 Results
Type
Article (86897)
Company Profile (704)
Press Release (765432)
Multimedia
Podcasts (148)
Webinars (19)
Section
Business (232826)
Career Advice (4133)
Deals (39763)
Drug Delivery (130)
Drug Development (91113)
Employer Resources (199)
FDA (18192)
Job Trends (17367)
News (396866)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1572)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (403)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (393)
Cancer (3104)
Cardiovascular disease (249)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74332)
Collaboration (1114)
Company closure (3)
Compensation (715)
Complete response letters (34)
COVID-19 (2905)
CRISPR (68)
C-suite (359)
Cystic fibrosis (122)
Data (3105)
Decentralized trials (2)
Denatured (52)
Depression (78)
Diabetes (380)
Diagnostics (6982)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (184)
Drug pricing (153)
Drug shortages (36)
Duchenne muscular dystrophy (138)
Earnings (97537)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131481)
Executive appointments (910)
FDA (19944)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1020)
Gene editing (149)
Generative AI (40)
Gene therapy (439)
GLP-1 (937)
Government (5265)
Grass and pollen (6)
Guidances (182)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3102)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (58)
Layoffs (595)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (216)
Machine learning (12)
Management (65)
Manufacturing (449)
MASH (100)
Medical device (14733)
Medtech (14738)
Mergers & acquisitions (22586)
Metabolic disorders (969)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (145)
Neuropsychiatric disorders (43)
Neuroscience (2333)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (126)
Parkinson's disease (201)
Partnered (25)
Patents (323)
Patient recruitment (174)
Peanut (55)
People (65733)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22941)
Phase II (32274)
Phase III (24302)
Pipeline (1710)
Policy (246)
Postmarket research (3552)
Preclinical (10360)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (529)
Real estate (7402)
Recruiting (76)
Regulatory (27191)
Reports (62)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (99)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (66)
The Weekly (94)
Vaccines (919)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (92)
Last 7 days (395)
Last 30 days (2013)
Last 365 days (34004)
2025 (18573)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50546)
Australia (8879)
California (7813)
Canada (2422)
China (728)
Colorado (340)
Connecticut (349)
Delaware (205)
Europe (115959)
Florida (1160)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (744)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1109)
Massachusetts (5977)
Michigan (276)
Minnesota (487)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2194)
New Mexico (31)
New York (2191)
North Carolina (1250)
North Dakota (10)
Northern California (3366)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1666)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2896)
Tennessee (130)
Texas (1199)
United States (29509)
Utah (231)
Virginia (215)
Washington D.C. (80)
Washington State (692)
West Virginia (4)
Wisconsin (86)
There are 853,034 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Pricing
BMS, Pfizer Join DTC Trend, Offering Eliquis to Patients for 40% Below List Price
In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer pitched the direct-to-consumer program as a way to allow uninsured, underinsured and self-pay patients to pay less out of pocket.
July 17, 2025
·
2 min read
·
Nick Paul Taylor
Layoffs
Sarepta Up 18% After Business Overhaul as Analysts Cautiously Optimistic
Sarepta Therapeutics appears to have right-sized itself after laying off over a third of its staff, announcing a significant pipeline shift and adding a black box warning to its Duchenne muscular dystrophy gene therapy Elevidys.
July 17, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Hairy Cell Leukemia Market to Surpass USD 223.3 Million in 2032, Driven by Rising Cases of Rare Hematologic Cancers | Coherent Market Insights
July 17, 2025
·
1 min read
Press Releases
NervGen Announces Leadership Transition to Support Strategic Growth and Expansion
Chairman Dr. Adam Rogers Appointed Interim CEO Following Landmark Positive Chronic Spinal Cord Injury Trial Results
July 17, 2025
·
7 min read
Press Releases
Maxwell Biosciences Announces AI Department & Hiring of Jon McClure
New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence
July 17, 2025
·
4 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q2 2025
The life sciences job market continues to shift.
BioSpace
’s Q2 2025 U.S. Life Sciences Job Market Report is now available, offering exclusive insights into the latest hiring trends, layoffs, and workforce dynamics across the life sciences industry.
July 17, 2025
·
1 min read
·
BioSpace Insights
Layoff Tracker
GSK Cuts Unspecified Number of R&D Staffers
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
July 17, 2025
·
159 min read
·
BioSpace Editorial Staff
Press Releases
ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer
July 17, 2025
·
19 min read
Press Releases
Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering
July 17, 2025
·
1 min read
Press Releases
Cycle Pharmaceuticals launches HARLIKU™ (nitisinone) Tablets, the first FDA-approved treatment for use in Alkaptonuria (AKU)
July 17, 2025
·
5 min read
1 of 85,304
Next
